Bovine Pericardial Valve Market Scope And Analysis

Report Code : TIPRE00008677
Category : Medical Device

No. of Pages : 150

Buy Now

Bovine Pericardial Valve Market Scope and Analysis by 2031

Buy Now

Bovine Pericardial Valve Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 2.60 Billion
Market Size by 2031	US$ 6.08 Billion
Global CAGR (2023 - 2031)	9.9%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Valve Type Aortic Mitral By Alloy Cobalt-chrome Titanium Nickel Molybdenum By End User Hospitals Cardiac Centers Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Edwards Lifesciences Medtronic Boston Scientific Labor Laboratories Meril Life Sciences Abbott Colibri Heart Valve LivaNova PLC Braile Biomedica Affluent Medical SA

Bovine Pericardial Valve Market News and Recent Developments

The Bovine Pericardial Valve Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for bovine pericardial valves:

Medtronic launched the Avalus Ultra valve, designed to facilitate ease of use at implant and lifetime patient management. The product is a next-generation surgical aortic tissue valve that features a polyetheretherketone (PEEK) base frame for consistent circularity, an industry-leading Effective Orifice Area (EOA) that allows for greater blood flow and a radiopaque coil for clear visibility for future valve-in-valve procedures (Source: Medtronic, Press Release, 2024)
Edwards Lifesciences Corporation launched the SAPIEN 3 Ultra RESILIA valve, which incorporates the company's RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve. RESILIA tissue is a bovine pericardial tissue treated with advanced anti-calcification technology. It serves as the platform for new valves, including the next-generation SAPIEN X4 valve undergoing clinical trials. (Source: Edwards Lifesciences, Company Website, 2022)

Bovine Pericardial Valve Market Report Coverage and Deliverables

The “Bovine Pericardial Valve Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles